Dimitar Tonev

Dimitar Tonev, Dr.

Drug Development Consultant in Hepatology and Virology

Dimitar Tonev graduated from Sofia Medical University and was trained as hepatologist and pharmaceutical physician in both his native Bulgaria and UK.

He has spent more than 25 years providing services to both big pharmaceutical companies (J&J, Novartis, Roche, BMS and Iqvia) as well as Biotech/Diagnostic/Device companies specialising in the areas of liver and viral diseases. Dimitar created Intercept medical organisation across EU, Canada and AUS/NZ and supported pivotal REGENERATE and POISE clinical trials. In the last few years, he has consulted liver programs of multiple small biotech companies in NASH, PBC, AIH, HBV and HDV. Leading Iqvia in Hepatology provided some unique knowledge of patient pathways, recruitment enrichment as well as patient search strategies in hospital Electronic Medical Records and non-invasive technologies assessing liver disease fibrosis and inflammation. He is a member of Liver Forum for collaborative research, LITMUS and NAIL NIT consortiums as well as the European Society of Diabetology NAFLD study group.

Advertizing
Advertizing

Other speakers in 2022

Rikke Nørgaard Elster

Denmark

Rikke Nørgaard Elster

Head of Mental Health Tech at We.Care
Psychologist | Specialized in Digital Therapeutics
Magdalena Daccord

Switzerland

Magdalena Daccord

Chief Executive
FH Europe, the European Network of patient organizations advocating for people living with familial hyperlipidaemias
Mireille Muller

Switzerland

Mireille Muller

Executive Regulatory Policy Director, Novartis
Part of several EFPIA groups / Part of the EuropaBio group on ATMPs and Policy
Skip to content